On February 28, 2025, QuantWave, the automated forecasting platform, issued a long signal for GSK PLC with a price of $37.16. After a successful prediction, the stock reached the target price of $41....
On April 2, 2025, QuantWave, the automated forecasting platform, issued a short signal for GSK PLC stock with a price target forecast of $34.44, a 7.44% profit from the signal price of $37.21....
GSK PLC, a global pharmaceutical company, is facing a class action lawsuit....
On February 27, 2025, QuantWave, an automated forecasting platform, issued a long signal for GSK PLC with a price target forecast of $39.93. The stock was trading at $36.87 at the time of the signal....
GSK plc, also known as GlaxoSmithKline, is facing a potential class action lawsuit from shareholders who have suffered financial losses....
AstraZeneca PLC (NASDAQ: AZN) recently faced a class action lawsuit, and The Gross Law Firm is reminding shareholders about an upcoming lead plaintiff deadline of February 21, 2025....
Regeneron Pharmaceuticals Inc. (REGN) is currently facing a class action lawsuit filed by investors....
The Pomerantz Law Firm is currently conducting an investigation into potential claims on behalf of investors of The Este Lauder Companies Inc. (NYSE:EL)....
GSK PLC, a global pharmaceutical company, is facing a class action lawsuit....
Investors in Visa Inc. (V) are advised to secure legal counsel as the company faces a securities class action lawsuit....